Online citations, reference lists, and bibliographies.
← Back to Search

Effect Of Hemithorax Irradiation Alone Or Combined With Doxorubicin And Cyclophosphamide In 47 Pleural Mesotheliomas: A Nonrandomized Phase II Study.

C. J. Lindén, C. Mercke, U. Albrechtsson, L. Johansson, S. B. Ewers
Published 1996 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In order to assess the value of radiotherapy in the treatment of pleural mesotheliomas, we studied tumour response and survival after hemithorax irradiation alone (RT), or radiotherapy combined with doxorubicin and cyclophosphamide chemotherapy (RTCT). Forty seven patients with pleural mesotheliomas received irradiation of the diseased hemithorax at 8 MV (megavolt) photons to a total dose of 40 Gy, administered in 20 daily fractions of 2 Gy for 5 days a week. One month after RT, patients aged < or = 70 yrs with a good performance status were offered supplementary chemotherapy (CT) with doxorubicin 30 mg.m-2 body surface on Day 1 and Day 8, combined with cyclophosphamide 600 mg.m-2 on Day 1, in cycles of 21 days. Tumour response was evaluated by computed axial tomography (CAT) before and 1 month after RT and/or CT. Only 3 of the 47 (95% confidence interval (95% CI)-0.6-13%) irradiated tumours responded with a partial response (PR). In 31 patients treated with RT alone, one PR was observed; whereas, in the combined treatment group, 2 out of 16 responded with PR to RT. CT with doxorubicin and cyclophosphamide induced only 2 out of 16 PRs (95% CI -3.4-28.4%), and the combined treatment consisting of RT followed by CT induced 2 out of 16 PRs. The median survival following the initiation of RT was 7 months in all patients (n = 47), 6 months in the RT group (n = 31), and 13 months in the combined RTCT group (n = 16). Chest pain, performance status and body weight were not favourably affected by the radiotherapy. We conclude that hemithorax irradiation of pleural mesotheliomas with a moderately high dose is not useful, since it produces no improvement in chest pain, few objective tumour responses and no prolongation of survival.
This paper references
10.1200/JCO.1989.7.8.1157
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
10.1136/thx.38.10.744
Evidence for longer survival of patients with pleural mesothelioma without asbestos exposure.
M. Law (1983)
The World Health Organization. Histological typing of lung tumours.
(1982)
10.1200/JCO.1993.11.8.1559
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
A. Chahinian (1993)
10.1016/0360-3016(92)90709-Q
Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation.
K. Mattson (1992)
10.1200/JCO.1988.6.3.527
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
A. Alberts (1988)
10.1016/S0022-5223(19)36578-X
Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
D. Sugarbaker (1991)
10.1016/0007-0971(83)90068-2
Malignant mesothelioma 1982: review of 4710 published cases.
G. Hillerdal (1983)
10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma
D. Karnofsky (1948)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.1002/IJC.2910410409
Survival patterns for malignant mesothelioma: The seer experience
R. Spirtas (1988)
10.1136/thx.39.4.255
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.
M. Law (1984)
Correlations between findings at computed tomography (CT) and at thoracoscopy/thoracotomy/autopsy in pleural mesothelioma.
P. Maasilta (1991)
10.1259/0007-1285-50-591-224
Reactivation of radiation pneumonitis by adriamycin.
D. Mclnerney (1977)
10.1016/S0012-3692(15)37393-1
Malignant mesothelioma. Current status and future prospects.
J. Aisner (1978)
Review of malignant mesotheliomas in Lund, Sweden, 1980–1990: histopathological and immunohistochemical features - preliminary results
L Johansson (1993)
Pleurectomy, intraoperative brachytherapy, and postoperative radiation in the management of malignant pleural mesothelioma
BS Hilaris (1984)
Mesothelioma chemotherapy
P. Ruffie (1993)
Malignant mesothelioma of the pleura: a prospective therapeutic study of 132 patients from 1981–1985
A Calavrezos (1988)
Extrapleural IRRADIATION OF PLEURAL MESOTHELIOMAS 2571 pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma
DJ Sugarbaker (1991)
10.1080/09553008014551861
WHO Handbook for Reporting Results of Cancer Treatment
R. Hunter (1980)
10.1177/030089168106700401
Histological Typing of Lung Tumours 1
E. Chaves (1981)
10.1136/oem.44.8.550
Ferruginous bodies and pulmonary fibrosis in dead low to moderately exposed asbestos cement workers: histological examination.
L. Johansson (1987)
Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma.
P. Sørensen (1985)
10.1016/0360-3016(84)90050-6
Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma.
B. Hilaris (1984)
Combined doxorubicin and radiation therapy in malignant pleural mesothelioma.
C. Sinoff (1982)
Benign and malignant mesothelioma
KH Antman (1993)
Das Pleuramesotheliom aus Strahlentherapeutischer Sicht
AC Voss (1974)
10.1002/AJIM.4700030407
Features of asbestos-exposed and unexposed mesothelioma.
A. Hirsch (1982)
10.1111/J.1445-5994.1982.TB02466.X
Conventional treatment and its effect on survival of malignant pleural mesothelioma in Western Australia.
A. Musk (1982)
10.1016/0360-3016(82)90379-0
Radiation therapy in the management of patients with mesothelioma.
W. Gordon (1982)
10.1097/00000421-199002000-00002
The Treatment of Malignant Mesothelioma of the Pleura: Review of a 5‐Year Experience, With Special Reference to Radiotherapy
D. Ball (1990)
Radiographic chest assessment of lung injury following hemithorax irradiation for pleural mesothelioma.
P. Maasilta (1991)
La radiothérapie des mésothéliomes pleuraux malins: a propos de 14 cas irradiés à doses élevées
F Eschwege (1973)
10.1016/0169-5002(92)90005-5
Malignant mesothelioma: prognostic factors in a prospective study of 98 patients
L. Tammilehto (1992)
10.1097/00000421-198602000-00020
Cancer : Principles and Practice of Oncology
V. Devita (1982)
10.1378/CHEST.107.6_SUPPLEMENT.332S
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)



This paper is referenced by
10.1007/0-387-28274-2_41
Treatment of Mesothelioma with Radiotherapy
R. P. Smith (2005)
Scuola di Dottorato in Scienze Fisiopatologiche e neuropsicobiologiche e assistenziali del ciclo della vita - Ciclo XXVIII
Roberto Weinstein (2015)
10.1007/s00063-002-1181-5
Prognose, Staging und Therapie des malignen Pleuramesothelioms
W. Neumeister (2002)
Radiotherapy for malignant pleural mesothelioma (Review)
Ellen Chapman (2010)
10.1097/JTO.0b013e3181834f66
Recent Advances in the Treatment of Malignant Pleural Mesothelioma
S. Ramalingam (2008)
10.1634/THEONCOLOGIST.12-7-850
Multidisciplinary treatment of malignant pleural mesothelioma.
G. Ceresoli (2007)
10.1016/S0169-5002(98)00072-5
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma.
A. Purohit (1998)
10.1378/CHEST.116.2.504
Advances in the treatment of malignant pleural mesothelioma.
D. Sterman (1999)
Contribution of activin signals to progression of malignant pleural mesothelioma and evaluation of therapeutic implications
J. Münzker (2011)
10.1038/sj.bjc.6600673
Chemotherapy for malignant pleural mesothelioma: past results and recent developments
S. Tomek (2003)
10.1016/S0039-6109(02)00033-6
Malignant mesothelioma: options for management.
S. Singhal (2002)
10.1097/00001622-200303000-00006
Chemotherapy for malignant pleural mesothelioma
S. Tomek (2003)
10.1016/j.ejca.2011.05.012
Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma.
P. Jenkins (2011)
10.1007/978-1-4615-1589-0_13
Malignant pleural mesothelioma.
L. Ho (2001)
10.1016/j.ctrv.2012.11.004
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations.
C. Pinto (2013)
10.1136/thoraxjnl-2017-211321
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse (2018)
A Novel Treatment for Malignant Mesothelioma by use of Cell Penetrating Peptide Based Kinase Inhibition
Isabella Lyn Gore (2017)
10.1186/1748-717X-4-35
Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma
B. Pehlivan (2009)
10.1097/01.LBR.0000011079.00225.DF
Treatment of Mesotheliomatous Pleural Effusion: Experimental Therapy versus Thoracoscopic Talc Poudrage? Pro: Talc Poudrage Therapy
Y. Aelony (2001)
10.1016/j.jtcvs.2015.02.020
Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
Hongyi Lei (2015)
10.1097/MCP.0b013e328302851d
Malignant mesothelioma 2008
M. Zervos (2008)
Explorer What Is the Role of Radiotherapy in Malignant Pleural Mesothelioma ?
A. Price (2017)
10.1016/j.lungcan.2009.03.016
Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets.
O. Røe (2010)
10.1016/B978-0-12-803523-8.00014-9
Site-Specific Symptom Management: Palliative Radiotherapy for Advanced and Metastatic Lung Cancer
R. Rhome (2017)
10.1002/14651858.CD003880.PUB4
Radiotherapy for malignant pleural mesothelioma.
E. Chapman (2006)
10.1016/j.lungcan.2013.11.004
Radiotherapy for the treatment of pain in malignant pleural mesothelioma: a systematic review.
N. Macleod (2014)
10.1111/j.1440-1843.2005.00763.x
Prolonged survival after talc poudrage for malignant pleural mesothelioma: Case series
Y. Aelony (2005)
10.1016/J.CRITREVONC.2003.10.001
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments.
A. Catalano (2004)
BIBLIOGRAPHIC REVIEW July 2016 Third Consensus Conference on Malignant Pleural Mesothelioma: State-of-the-art and recommendations
(2016)
10.1007/s00066-003-1055-7
Stereotactic Intensity-Modulated Radiation Therapy (IMRT) and Inverse Treatment Planning for Advanced Pleural Mesothelioma
M. Muenter (2003)
10.1053/J.SEMINONCOL.2005.02.010
New agents in the management of advanced mesothelioma.
N. Vogelzang (2005)
10.1093/ANNONC/MDF664
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
G. Jerusalem (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar